Table 1 Association between RALYL expression and clinicopathologic features in 117 HCC cases.

From: RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-β2

Features Total RALYL expressiona P-value
Absent Present
Sex     0.985
   Male 98 72 26  
   Female 19 14 5  
Age (years)     0.812
   ≤60 96 71 25  
   >60 21 15 6  
Serum AFP (ng/mL)     0.075
   ≤400 65 52 13  
   >400 52 34 18  
Serum HBsAg     0.643
   Negative 16 11 5  
   Positive 101 75 26  
Cirrhosis     0.047
   Absent 36 22 14  
   Present 80 63 17  
Differentiation     0.044
   Well/moderate 67 54 13  
   Poor 50 32 18  
Tumor size     0.205
   ≤5 49 39 10  
   >5 68 47 21  
TNM stage (AJCC)     0.559
   I 84 63 21  
II/III 33 23 10  
Vascular invasion     0.020
   Absent 102 78 24  
   Present 13 6 7  
Metastasis     0.032
   Absent 57 47 10  
   Present 60 39 21  
CD133     0.003
   Low 78 64 14  
   High 39 22 17  
TGF-β2     0.029
   Absent 72 58 14  
   Present 45 28 17  
  1. Pearson χ2 test.
  2. Statistical significance (P < 0.05) is shown in bold.
  3. #Partial data are not available, and the statistic was based on available.
  4. aRALYL absent: Samples without RALYL detection by qRT-PCR; RALYL present: Samples detected with RALYL expression by qRT-PCR.